Nano-antioxidants: An emerging strategy for intervention against neurodegenerative conditions

Neurochemistry International
Rajat SandhirNitin Singhal

Abstract

Oxidative stress has for long been linked to the neuronal cell death in many neurodegenerative conditions. Conventional antioxidant therapies have been less effective in preventing neuronal damage caused by oxidative stress due to their inability to cross the blood brain barrier. Nanoparticle antioxidants constitute a new wave of antioxidant therapies for prevention and treatment of diseases involving oxidative stress. It is believed that nanoparticle antioxidants have strong and persistent interactions with biomolecules and would be more effective against free radical induced damage. Nanoantioxidants include inorganic nanoparticles possessing intrinsic antioxidant properties, nanoparticles functionalized with antioxidants or antioxidant enzymes to function as an antioxidant delivery system. Nanoparticles containing antioxidants have shown promise as high-performance therapeutic nanomedicine in attenuating oxidative stress with potential applications in treating and preventing neurodegenerative conditions. However, to realize the full potential of nanoantioxidants, negative aspects associated with the use of nanoparticles need to be overcome to validate their long term applications.

References

Jan 1, 1990·Free Radical Research Communications·A SamuniA Russo
Jan 1, 1989·Neuroscience and Biobehavioral Reviews·W A Banks, A J Kastin
Sep 1, 1987·Metabolism: Clinical and Experimental·W M PardridgeJ Yang
Mar 1, 1987·Metabolic Brain Disease·P Divakaran, R C Wiggins
Oct 1, 1985·Journal of Neurochemistry·G W Konat, R C Wiggins
Apr 1, 1983·Biochemical Pharmacology·B Havsteen
Jun 1, 1994·Free Radical Biology & Medicine·Y HanasakiS Fukui
Oct 1, 1996·The Journal of Pharmacy and Pharmacology·T MinagawaA Tsuji
Apr 1, 1996·Biological & Pharmaceutical Bulletin·M UchidaM Shinoda
Feb 26, 2000·Trends in Pharmacological Sciences·M LindgrenU Langel
Jun 1, 2000·Free Radical Biology & Medicine·P AderS Wolffram
Feb 13, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·K S SoppimathW E Rudzinski
Apr 21, 2001·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·R J RodriguezD R Buhler
May 2, 2001·Parkinsonism & Related Disorders·L L. DuganK L. O'Malley
Feb 23, 2002·Drug Development and Industrial Pharmacy·P R LockmanD D Allen
Jun 14, 2002·International Journal of Pharmaceutics·Tatiana S LevchenkoVladimir P Torchilin
Aug 6, 2002·Neuroscience Letters·Ali M SharifiMasoomeh Bakhshayesh
Aug 8, 2002·Journal of Drug Targeting·Jörg KreuterRenad Alyautdin
Mar 19, 2003·Journal of Neurochemistry·Kuresh A YoudimCatherine Rice-Evans
Apr 23, 2003·Advanced Drug Delivery Reviews·Christine VauthierPatrick Couvreur
May 3, 2003·Molecular Therapy : the Journal of the American Society of Gene Therapy·A FlierlD C Wallace
Jun 6, 2003·Journal of Neurochemistry·Duncan G MacGregorMargaret E Rice
Jun 17, 2003·The Journal of Pharmacology and Experimental Therapeutics·Gregory J R Charrois, Theresa M Allen
Aug 28, 2003·Drug News & Perspectives·Vinicio Granados-Soto
Aug 29, 2003·The Journal of Biological Chemistry·N D SonawaneA S Verkman
Dec 4, 2003·European Journal of Medicinal Chemistry·Susanna BosiMaurizio Prato
Dec 4, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Paul R LockmanDavid D Allen
Jan 6, 2004·Free Radical Research·Amanpreet SinghShrinivas K Kulkarni
Jan 22, 2004·Bioconjugate Chemistry·Serguei V VinogradovAlexander V Kabanov
Mar 12, 2004·Journal of Pharmaceutical and Biomedical Analysis·Tayade Pralhad, Kale Rajendrakumar
Aug 25, 2004·Science·Andrew E PellingJames K Gimzewski
Mar 11, 2005·Advanced Drug Delivery Reviews·Jing-Shi ZhangLeaf Huang
Mar 22, 2005·Molecular Nutrition & Food Research·Elisabeth Wenzel, Veronika Somoza
Jun 25, 2005·Current Alzheimer Research·John M RingmanJeffrey L Cummings
Jul 20, 2005·Anti-cancer Drugs·Ralf-Dieter HofheinzAndreas Hochhaus
Jul 27, 2005·Bone Marrow Transplantation·P WindrumUNKNOWN EBMT Chronic Leukaemia Working Party Complications Subcommittee

❮ Previous
Next ❯

Citations

Mar 2, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Sung Won HwangKyung-Jin Yeum
Apr 8, 2016·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Nesrine SifiFatima Laraba-Djebari
May 6, 2016·Oxidative Medicine and Cellular Longevity·Alexander V Maksimenko
Jun 9, 2016·Journal of Biochemical and Molecular Toxicology·Amina Ladjel-MendilFatima Laraba-Djebari
Feb 2, 2017·Drug Development and Industrial Pharmacy·Oscar Escalona-RayoDavid Quintanar-Guerrero
Jul 19, 2018·Toxicology Mechanisms and Methods·Saba KhanamYasir Hasan Siddique
Apr 1, 2020·Pharmaceutics·Francisco ArriagadaJavier Morales
Apr 21, 2018·Science China. Life Sciences·Wang Ran, Xue Xue
Jan 31, 2020·Frontiers in Bioengineering and Biotechnology·Alexander VaisermanOleh Lushchak
Dec 28, 2017·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Hamed AmaniOmid Akhavan
Jun 13, 2018·Current Nutrition Reports·Kelsea R GildawieAmanda N Carey
Jul 28, 2018·Oxidative Medicine and Cellular Longevity·Oleh LushchakAlexander Vaiserman
Jul 1, 2019·Biological Trace Element Research·Srinath RajeswaranRavikumar Vilwanathan
Jan 1, 2020·Antioxidants·Ibrahim KhalilAli Seyfoddin
Aug 22, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Shaista Chaudhary, Suhel Parvez
Apr 6, 2021·Oxidative Medicine and Cellular Longevity·Guini SongYue He

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Related Papers

Annals of the New York Academy of Sciences
Neeraj SinghBeverly A Rzigalinski
Infectious Disorders Drug Targets
Shaadi F ElswaifiBeverly A Rzigalinski
Anales del sistema sanitario de Navarra
J M Irache
Advances in Colloid and Interface Science
Kannan Badri Narayanan, Hyun Ho Park
© 2021 Meta ULC. All rights reserved